Kirkeby Cell Therapy APS: Financial statements 2021
CVR: 38650165
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Kirkeby Cell Therapy APS (CVR 38650165) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 246,593 and a net result of DKK 281,249 compared with DKK 183,657 the year before. That is an increase of 36.6% compared with the year before. Equity in the 2021 report amounted to DKK 1,577,022. The solvency ratio was 96%.
- Gross Profit
- DKK 246,593
- Profit/Loss
- DKK 281,249
- Equity
- DKK 1,577,022
- Total Assets
- DKK 1,643,532
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 247K | 281K | 1.6M | - |
| 2020 | - | 180K | 184K | 1.3M | - |
| 2019 | - | 189K | 256K | 1.1M | - |
| 2018 | - | 120K | 71K | 937K | - |
Official annual report
Find more companies like Kirkeby Cell Therapy APS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 11, 2021, the company changed its name from Kirkeby Cell Therapy IVS to Kirkeby Cell Therapy APS.
Kirkeby Cell Therapy APS has published its annual report for 2020. Gross profit came to DKK 180,483, and the net result was DKK 183,657.
About Kirkeby Cell Therapy APS
Kirkeby Cell Therapy APS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Kirkeby Cell Therapy IVS and Kirkeby Cell Therapey IVS. The management consists of Agnete Kirkeby. The company is owned by Agnete Kirkeby. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 25,872 and a net result of DKK -19,504 compared with DKK 111,159 the year before. Equity in the 2025 report amounted to DKK 1,541,351.